These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3806960)

  • 1. [Pharmacokinetics of cefoperazone in end-stage renal failure patients on peritoneal dialysis].
    Okuda T; Katoh T; Takaichi K; Matsunaga H; Uchida S; Kurokawa K; Nihei H
    Jpn J Antibiot; 1986 Oct; 39(10):2775-9. PubMed ID: 3806960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of cefoperazone concentration in human lung tissue].
    Monden Y; Fujimoto Y; Nakahara K
    Jpn J Antibiot; 1986 Jan; 39(1):57-62. PubMed ID: 3702062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the levels of cefoperazone in urological organs].
    Fukatsu H; Waki M; Hatano Y; Hiraiwa S; Kikuchi T; Muramatsu T; Yamada Y; Nishikawa E; Satoh T; Honda N
    Hinyokika Kiyo; 1985 Jun; 31(6):1085-91. PubMed ID: 4061208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
    Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies with cefoperazone in the biliary disease].
    Morinaga T; Furukawa M; Nakata T; Yamada R; Itoh S; Maeda S; Itose K; Ohtsubo M
    Jpn J Antibiot; 1985 Jan; 38(1):128-32. PubMed ID: 3989972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
    Toyonaga Y; Kurosu Y; Nakamura H; Sugita M; Takahashi T; Hori M
    Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1984 Nov; 37(11):2213-22. PubMed ID: 6098715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
    Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
    Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of cefoperazone levels in the cerebrospinal fluid of patients with hydrocephalus].
    Asahi S; Mori N; Tajika Y; Kagawa M
    Jpn J Antibiot; 1985 Jan; 38(1):121-7. PubMed ID: 3989971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.
    Hayashi T; Watanabe Y; Kumano K; Kitayama R; Yasuda T; Saikawa I; Totsuka K; Kumada T; Shimizu K
    J Antibiot (Tokyo); 1986 May; 39(5):699-712. PubMed ID: 3733519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of prostatic tissue levels of cefoperazone].
    Yoshida H; Hoshino M; Haraguchi C; Ogawa Y; Kawai N; Sakurai H; Ishihara Y; Higaki Y; Imamura K
    Hinyokika Kiyo; 1985 May; 31(5):871-4. PubMed ID: 2413746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications.
    Hodler JE; Galeazzi RL; Frey B; Rudhardt M; Seiler AJ
    Eur J Clin Pharmacol; 1984; 26(5):609-12. PubMed ID: 6468477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K
    Jpn J Antibiot; 1984 Oct; 37(10):1939-55. PubMed ID: 6094873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
    Tourkantonis A; Nicolaidis P
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of multiple-dose cefoperazone in hemodialysis patients.
    Spyker DA; Richmond JD; Scheld WM; Bolton WK
    Am J Nephrol; 1985; 5(5):355-60. PubMed ID: 4061504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
    Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Ito K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1984 Nov; 37(11):2193-202. PubMed ID: 6098712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of cefoperazone in liver diseases].
    Kakiuchi S; Tagawa S; Tameda Y; Kosaka Y
    Jpn J Antibiot; 1985 Aug; 38(8):2026-32. PubMed ID: 4078997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.